login

Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency

European Journal of PediatricsPublished 1 June 1984
U. Wendel, H. J. Bremer
Citations99
SJR quartileQ1
SJR score0.93
SNIP1.20

TL;DR

In a 3-year-old mentally retarded girl with homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency among different therapeutic approaches only treatment with betaine resulted in a satisfactory biochemical response.

Abstract

In a 3-year-old mentally retarded girl with homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency among different therapeutic approaches only treatment with betaine (15-20 g/day) resulted in a satisfactory biochemical response. Betaine improved homocysteine remethylation and thus lowered plasma homocystine to trace amounts and normalized the previously very low plasma methionine concentration. This biochemical response was associated with a clinical improvement although she remained mentally retarded.

Keywords

MedicineBiochemistry, Genetics and Molecular Biology